Felix von Podewils
Overview
Explore the profile of Felix von Podewils including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
714
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Strzelczyk A, Schubert-Bast S, von Podewils F, Knake S, Mayer T, Klotz K, et al.
Epilepsy Behav
. 2025 Mar;
166:110302.
PMID: 40073826
Background: Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) are rare and debilitating forms of epilepsy, characterised by recurrent, severe, drug-resistant seizures and neurodevelopmental impairments. A non-euphoric, plant-derived, highly purified formulation...
2.
Kalousios S, Hesser J, Dumpelmann M, Baumgartner C, Hamer H, Hirsch M, et al.
BMJ Open
. 2025 Feb;
15(2):e089903.
PMID: 39956604
Introduction: A novel focal cortex stimulation (FCS) device has recently received approval in Europe for patients with focal drug-resistant epilepsy (DRE). After 6 months of stimulation, 17 of 32 patients...
3.
Strzelczyk A, von Podewils F, Hamer H, Knake S, Rosenow F, Klotz K, et al.
CNS Drugs
. 2025 Feb;
39(3):321-331.
PMID: 39954117
Background: In randomised controlled trials, adjunctive cenobamate (CNB) has been shown to reduce seizure frequency in patients with drug-resistant focal epilepsy. Studies conducted in real-world settings provide valuable complementary data...
4.
Buhleier E, Schubert-Bast S, Knake S, von Podewils F, Hamer H, Melzer N, et al.
Epilepsia
. 2025 Feb;
PMID: 39932331
Objective: This study was undertaken to evaluate retention and treatment characteristics of cenobamate (CNB) in patients with developmental and epileptic encephalopathies (DEEs) in clinical practice. Methods: This multicenter, retrospective cohort...
5.
Reckin L, Jeschke S, von Podewils F, Giessler J, Schmidt-Schuchert S, Tomczyk S, et al.
Epilepsy Behav
. 2025 Feb;
164:110285.
PMID: 39893703
Purpose: The primary objective of this exploratory study was to examine the current situation of people with epilepsy (PWE) in the German labor market and how epilepsy affects their daily...
6.
Lappe L, Hertzberg C, Knake S, Knuf M, von Podewils F, Willems L, et al.
Neurol Res Pract
. 2024 May;
6(1):29.
PMID: 38812055
Background: Depending on the underlying etiology and epilepsy type, the burden of disease for patients with seizures can vary significantly. This analysis aimed to compare direct and indirect costs and...
7.
Maltseva M, Rosenow F, von Podewils F, Habermehl L, Langenbruch L, Bierhansl L, et al.
Seizure
. 2024 Apr;
118:58-64.
PMID: 38642445
Background: Seizure clusters, prolonged seizures, and status epilepticus are life-threatening neurological emergencies leading to irreversible neuronal damage. Benzodiazepines are current evidence-based rescue therapy options; however, recent investigations indicated the prescription...
8.
Chen J, Ngo A, Rodriguez-Cruces R, Royer J, Caligiuri M, Gambardella A, et al.
bioRxiv
. 2024 Mar;
PMID: 38496668
Objectives: Temporal lobe epilepsy (TLE) is commonly associated with mesiotemporal pathology and widespread alterations of grey and white matter structures. Evidence supports a progressive condition although the temporal evolution of...
9.
Greguletz P, Plotz M, Baade-Buttner C, Bien C, Eisenhut K, Geis C, et al.
J Neurol
. 2024 Feb;
271(5):2736-2744.
PMID: 38386048
Autoantibodies against contactin-associated protein 2 (Caspr2) not only induce limbic autoimmune encephalitis but are also associated with pain conditions. Here, we analyzed clinical data on pain in a large cohort...
10.
Goncalves A, Mayer I, Schulz R, Floel A, von Podewils F, Angermaier A, et al.
BMC Health Serv Res
. 2023 Sep;
23(1):1021.
PMID: 37736723
Background: A significant and growing portion of the global burden of diseases is caused by neurological disorders. Tele-neurology has the potential to improve access to health care services and the...